In their study on CD47 expression in patients with malignant melanoma, Fu et al. [36] demonstrated that tumors in advanced TNM stages (III–IV) had a higher level of CD47 expression compared to tumors in lower TNM stages (I–II). The gene discussed is CD47; the disease is melanoma.